Decentralized studies are becoming increasingly common as a result of COVID-19. Will this trend continue? Join Darshan Kulkarni as he talks with guests Kelly Willenberg and Geoffrey Schick about the challenges presented by decentralized studies, and why this new way of conducting studies might not be ideal. Plus, we’ll discuss what the future clinical trial patient may look like.

Are Decentralized Studies Dead?

Welcome to DarshanTalks!&nbsp; We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!&nbsp; Powered By The Kulkarni Law Firm -&nbsp; Helping regulators see your business the way you do.&nbsp; We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.&nbsp;

Society & Culture

Documentary

Science

Education

How To

Life Sciences

Welcome to DarshanTalks!  We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!  Powered By The Kulkarni Law Firm -  Helping regulators see your business the way you do.  We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career. 

Share Are Decentralized Studies Dead?

Sign up to save your podcasts

Are Decentralized Studies Dead?

Are Decentralized Studies Dead?

More shows like DarshanTalks Podcast

Up First from NPR